A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease

NCT00000938 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

NIH

Sponsor class

Conditions

Lyme Disease

Interventions

DRUG: ceftriaxone
DRUG: doxycycline

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)